Lipe & Dalton’s Morgan Stanley MS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.99M | Sell |
19,101
-1,424
| -7% | -$282K | 1.86% | 21 |
|
|
2026
Q1 | $3.38M | Sell |
20,525
-398
| -2% | -$68.9K | 1.77% | 21 |
|
|
2025
Q4 | $3.71M | Sell |
20,923
-1,831
| -8% | -$305K | 1.83% | 16 |
|
|
2025
Q3 | $3.62M | Sell |
22,754
-373
| -2% | -$55.1K | 1.79% | 18 |
|
|
2025
Q2 | $3.26M | Buy |
23,127
+2
| +0% | +$246 | 1.76% | 21 |
|
|
2025
Q1 | $2.7M | Sell |
23,125
-2,537
| -10% | -$327K | 1.51% | 23 |
|
|
2024
Q4 | $3.23M | Sell |
25,662
-1,060
| -4% | -$131K | 1.71% | 19 |
|
|
2024
Q3 | $2.79M | Sell |
26,722
-298
| -1% | -$30K | 1.41% | 27 |
|
|
2024
Q2 | $2.63M | Sell |
27,020
-198
| -0.7% | -$18.8K | 1.41% | 25 |
|
|
2024
Q1 | $2.56M | Buy |
27,218
+3
| +0% | +$264 | 1.32% | 27 |
|
|
2023
Q4 | $2.54M | Sell |
27,215
-23
| -0.1% | -$1.84K | 1.38% | 25 |
|
|
2023
Q3 | $2.23M | Sell |
27,238
-23
| -0.1% | -$2K | 1.34% | 26 |
|
|
2023
Q2 | $2.33M | Sell |
27,261
-823
| -3% | -$70.4K | 1.33% | 26 |
|
|
2023
Q1 | $2.47M | Sell |
28,084
-1,898
| -6% | -$177K | 1.41% | 25 |
|
|
2022
Q4 | $2.55M | Sell |
29,982
-848
| -3% | -$72.3K | 1.47% | 25 |
|
|
2022
Q3 | $2.44M | Buy |
30,830
+2
| +0% | +$169 | 1.53% | 22 |
|
|
2022
Q2 | $2.35M | Buy |
30,828
+2
| +0% | +$164 | 1.37% | 26 |
|
|
2022
Q1 | $2.69M | Sell |
30,826
-349
| -1% | -$33.7K | 1.32% | 28 |
|
|
2021
Q4 | $3.06M | Sell |
31,175
-1,123
| -3% | -$112K | 1.45% | 26 |
|
|
2021
Q3 | $3.14M | Sell |
32,298
-174
| -0.5% | -$17.2K | 1.61% | 24 |
|
|
2021
Q2 | $2.98M | Sell |
32,472
-99
| -0.3% | -$8.49K | 1.55% | 26 |
|
|
2021
Q1 | $2.53M | Sell |
32,571
-299
| -0.9% | -$22.9K | 1.4% | 27 |
|
|
2020
Q4 | $2.25M | Buy |
32,870
+12
| +0% | +$689 | 1.39% | 27 |
|
|
2020
Q3 | $1.59M | Sell |
32,858
-274
| -0.8% | -$13.8K | 1.1% | 33 |
|
|
2020
Q2 | $1.6M | Sell |
33,132
-498
| -1% | -$20.9K | 1.16% | 30 |
|
|
2020
Q1 | $1.14M | Sell |
33,630
-1,049
| -3% | -$49.4K | 0.97% | 36 |
|
|
2019
Q4 | $1.77M | Sell |
34,679
-498
| -1% | -$23.6K | 1.18% | 32 |
|
|
2019
Q3 | $1.5M | Sell |
35,177
-1,673
| -5% | -$71.5K | 1.1% | 32 |
|
|
2019
Q2 | $1.61M | Sell |
36,850
-599
| -2% | -$26.7K | 1.15% | 33 |
|
|
2019
Q1 | $1.58M | Sell |
37,449
-1,374
| -4% | -$57.8K | 1.16% | 32 |
|
|
2018
Q4 | $1.54M | Sell |
38,823
-598
| -2% | -$26.1K | 1.25% | 30 |
|
|
2018
Q3 | $1.84M | Sell |
39,421
-449
| -1% | -$21.9K | 1.25% | 32 |
|
|
2018
Q2 | $1.89M | Sell |
39,870
-45,895
| -54% | -$2.4M | 1.39% | 30 |
|
|
2018
Q1 | $4.63M | Sell |
85,765
-923
| -1% | -$51.1K | 3.31% | 8 |
|
|
2017
Q4 | $4.55M | Sell |
86,688
-12,042
| -12% | -$609K | 3.14% | 12 |
|
|
2017
Q3 | $4.76M | Sell |
98,730
-20,135
| -17% | -$934K | 3.34% | 9 |
|
|
2017
Q2 | $5.3M | Sell |
118,865
-2,975
| -2% | -$128K | 3.43% | 5 |
|
|
2017
Q1 | $5.22M | Sell |
121,840
-3,175
| -3% | -$141K | 3.78% | 6 |
|
|
2016
Q4 | $5.28M | Buy |
125,015
+1,150
| +0.9% | +$43.5K | 3.76% | 5 |
|
|
2016
Q3 | $3.97M | Buy |
123,865
+60,275
| +95% | +$1.8M | 2.66% | 13 |
|
|
2016
Q2 | $1.65M | Buy |
+63,590
| New | +$1.66M | 1.14% | 33 |
|
Other funds holding MS
Lipe & Dalton's MS Position: Q2 2026 in Review
Lipe & Dalton reduced its Morgan Stanley (MS) stake by 6.9% in Q2 2026, selling an estimated $282K and leaving 19,101 shares worth $3.99M. The position accounts for 1.86% of the portfolio, ranked #21.
Lipe & Dalton first reported a position in MS in Q2 2016 and has held it in 41 quarters since. The position peaked at $5.3M in Q2 2017. 2,721 funds tracked by Wall St. Rank hold MS as of Q2 2026.
- Lipe & Dalton held 19,101 shares of Morgan Stanley worth $3.99M as of Q2 2026.
- Lipe & Dalton sold 1,424 Morgan Stanley shares in Q2 2026, an estimated $282K.
- Morgan Stanley made up 1.86% of Lipe & Dalton's portfolio in Q2 2026, its #21 holding.
- Lipe & Dalton first reported a position in Morgan Stanley in Q2 2016 and has held it in 41 quarters since.
- Lipe & Dalton's Morgan Stanley position peaked at $5.3M in Q2 2017.
- 2,721 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.
Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.